We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Same-Day Discharge Safe for Minimally Invasive Myomectomy

By HospiMedica International staff writers
Posted on 24 Feb 2016
Discharging women on the same day of undergoing minimally invasive myomectomy appears to be a safe option, according to a new study.

Researchers at Kaiser Permanente Northern California (Oakland, USA) conducted a retrospective case series involving 403 women who underwent minimally invasive myomectomy and were discharged the same day in order to estimate readmission rates. More...
The chart review was performed for outcomes of interest, including emergency department (ED) and urgent clinic visits within 48 hours, at seven days, and up to three months later, along with surgical and demographic characteristics.

The results showed that 88% of the patients were discharged to home the same day. Within 48 hours, just two patients (0.6%) were readmitted, both for postoperative fever, while seven patients (2%) visited the ED for pain or urinary retention; none of the patients made urgent care visits, and no patients were readmitted for life-threatening events or reoperation. A total of five patients (1.4%) were readmitted within three months. The study was published in the March 2016 issue of Obstetrics & Gynecology.

“Same-day discharge after minimally invasive myomectomy was found to have a low readmission rate and low health care utilization in the immediate postoperative period,” concluded lead author Katie Alton, MD, and colleagues. “Same-day discharge appears to be a safe option for healthy patients after undergoing an uncomplicated minimally invasive myomectomy.”

Myomectomy is a surgical procedure to remove uterine fibroids (leiomyomas), common noncancerous growths that appear in the uterus usually during childbearing years. Unlike a hysterectomy, which removes the entire uterus, myomectomy removes only the fibroids and leaves the uterus intact. Women who undergo myomectomy report improvement in fibroid symptoms, including heavy menstrual bleeding and pelvic pressure.

Related Links:

Kaiser Permanente Northern California



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.